Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 879 results for "sanofi"

Sanofi art exhibition of 'Life and Hope'

Updated: 2015-01-29 09:11 By Tang Zhihao(China Daily) Children drew during the ceremony for Sanofi's donation of artwork to the Shanghai Children's Medical Center on Jan 22. Photos provided to China Daily Child patients at Shanghai ... CHINAdaily USA, 5 hours ago
[x]  

46 images for sanofi

American Banking News, 5 days ago
ClinicSpace, 2 days ago
Fidelity Brokerage Services LLC, 6 days ago
Business World Intelligence, 2 days ago
Yahoo! News Australia, 6 days ago
Business Insider, 6 days ago
Yahoo! News, 6 days ago
Pharma Letter, 6 days ago
4 Traders, 6 days ago
Reuters UK, 6 days ago
Reuters

Sanofi And Regeneron's Cholestrol Drug Race

Sanofi and Regeneron may have a month's headstart on the market before facing competition from Amgen for their cholesterol drug. Sanofi and Regeneron announced on Monday that FDA had accepted for priority review the Biologics License Application ...
 International Business Times Australia4 hours ago Sanofi and Regeneron Announce Positive Topline Results from Phase 3 Trials Evaluating Monthly Alirocumab  Drugs.com1 day ago Sanofi, Regeneron announce positive trials of cholesterol drug  Economic Times2 weeks ago Sanofi, Regeneron cholesterol drug also effective in monthly doses  Reuters2 weeks ago
[x]  

Sanofi Volunteers + Continuous Improvement Know How = Success for Midland School

For most nonprofit organizations, resources are tight. Hiring specialists to provide professional expertise can be out of reach. That's why the Midland School in North Branch, N.J., is grateful for all Joel Gross and Bill Kelley, Senior Manager and ...
 Individual.com9 hours ago

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Sanofi

Law Offices of Howard G. Smith reminds investors that purchasers of the securities of Sanofi (the Company) ( NYSE:SNY ) have until February 2, 2015, to file a motion to be appointed as lead plaintiff in the shareholder ...
 SearchBug15 hours ago SANOFI : INVESTOR ALERT: Law Offices of Howard G. Smith Announces Lead Plaintiff Deadline In The Class Action Lawsuit Against Sanofi  4 Traders15 hours ago INVESTOR ALERT: Class Action Lawsuit Against Sanofi Announced by Law Offices of Howard G. Smith  BioSpace1 week ago SANOFI : Class Action Lawsuit Against Sanofi Announced by Law Offices of Howard G. Smith  4 Traders1 week ago
[x]  

Capstone Therapeutics Corp : Capstone Could Succeed with AEM-28 Where Aegerion and Sanofi Failed

/ Cholesterol-reducing statins like Pfizer's ( NYSE:PFE ) Lipitor may be the best selling prescription drug class in history, but for one kind of cholesterol disease, statins are just a pharmacological drop in the bucket. Homozygous familial ...
 4 Traders16 hours ago Capstone Could Succeed with AEM-28 Where Aegerion and Sanofi Failed  Yahoo! Finance15 hours ago

Sanofi India to hold board meeting

On 20 February 2015
 Business Standard1 day ago
Pharmaceutical Business Review

Drugmakers race to bring new cholesterol drugs to US market

New York REGENERON Pharmaceuticals Inc and Sanofi may get a head start on their biggest competitor in bringing a new class of cholesterol drugs to the US market. The US Food and Drug Administration (FDA) has until July 24 to make a decision on ...
 Business Times Singapore2 days ago Hypercholesterolemia Treatment Granted FDA Priority Review  Pharmacy Times1 day ago Sanofi and Regeneron's Praluent BLA gains priority review from US FDA26-01-2015  Pharma Letter1 day ago Sanofi SA And Regeneron Pharmaceuticals Inc Edge Past Amgen In The PCSK9 Race  Bidness Etc2 days ago
[x]  

Amgen Leapfrogged In Race For New Cholesterol Drug

Early on Monday Sanofi and Regeneron leapfrogged theirrival Amgen to gain leadership in the race to bring a new class of cholesterol drugs to market. The new development could potentially giveSanofi and Regeneron a month on the market by itself ...
 Forbes.com2 days ago Sanofi And Regeneron Leapfrog Amgen In New Cholesterol Drug Race  Austin American Statesman2 days ago ViewPoints: Sanofi/Regeneron succeed in plan to leapfrog Amgen in PCSK9 race will they be willing to compete on price?  FirstWord Pharma2 days ago

FDA accepts cholesterol-lowering med BLA under priority review

07:31 ET | By: Douglas W. House, SA News Editor Regeneron Pharmaceuticals (NASDAQ:REGN) and Sanofi (NYSE:SNY) announced that the FDA has accepted under priority review the Biologics License Application (BLA) for Praluent (alirocumab) for the ...
 Seeking Alpha2 days ago Regeneron Pharmaceuticals and Sanofi's BLA for Praluent accepted for priority review by US FDA  BusinessWeek2 days ago

Potential Sanofi (SNY) Trade Has 4.48% Downside Protection

The patented option-trade picking algorithms that power MarketIntelligenceCenter.com's Artificial Intelligence Center have selected a covered-call trade on Sanofi-Aventis (http://www.marketintelligencecenter.com/symbol/SNY"SNY) that includes 4.48% ...
 Individual.com2 days ago Potential Sanofi (SNY) Trade Targets 2.79% Return  Individual.com15 hours ago Sanofi (SNY) Showing Support Near $45.77  Individual.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less